US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 0.678
  • -0.004-0.63%
Trading Apr 25 13:10 ET
2.44MMarket Cap-10P/E (TTM)

Aptevo Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
-74.67%3.11M
0
0
0
28.62%3.11M
Operating revenue
--0
--0
--0
--0
--0
-74.67%3.11M
--0
--0
--0
28.62%3.11M
Cost of revenue
Gross profit
Operating expense
-9.06%28.88M
-16.92%6.38M
-15.71%6.56M
8.15%8.18M
-11.11%7.76M
-5.75%31.76M
-0.27%7.68M
-0.79%7.78M
-14.38%7.56M
-6.27%8.73M
Selling and administrative expenses
-15.15%11.77M
-7.21%2.79M
-19.14%2.67M
-26.54%2.72M
-7.02%3.59M
-5.61%13.87M
-4.81%3.01M
-4.94%3.31M
-10.05%3.7M
-2.23%3.86M
-General and administrative expense
-15.15%11.77M
-7.21%2.79M
-19.14%2.67M
-26.54%2.72M
-7.02%3.59M
-5.61%13.87M
-4.81%3.01M
-4.94%3.31M
-10.05%3.7M
-2.23%3.86M
Research and development costs
-4.33%17.11M
-23.17%3.59M
-13.18%3.89M
41.32%5.46M
-14.34%4.17M
-5.85%17.88M
2.88%4.67M
2.52%4.48M
-18.15%3.87M
-9.25%4.87M
Operating profit
-0.83%-28.88M
16.92%-6.38M
15.71%-6.56M
-8.15%-8.18M
-38.23%-7.76M
-33.84%-28.64M
-90.20%-7.68M
-63.87%-7.78M
-32.16%-7.56M
18.54%-5.61M
Net non-operating interest income expense
Other net income (expense)
-71.31%10.23M
-92.54%188K
1,008.00%227K
-99.35%230K
523.28%9.58M
545.24%35.66M
198.59%2.52M
98.93%-25K
1,612.51%35.42M
-189.51%-2.26M
Special income (charges)
--9.65M
--0
--0
--0
--9.65M
--0
--0
--0
--0
--0
-Gain on sale of property,plant,equipment
--9.65M
--0
--0
--0
--9.65M
--0
--0
--0
--0
--0
Other non- operating income (expenses)
-98.38%578K
-92.54%188K
1,008.00%227K
-99.35%230K
97.04%-67K
545.24%35.66M
198.59%2.52M
98.93%-25K
1,612.51%35.42M
-189.51%-2.26M
Income before tax
-365.90%-18.65M
-20.01%-6.2M
18.89%-6.33M
-128.53%-7.95M
123.20%1.83M
123.85%7.01M
21.74%-5.16M
-10.34%-7.81M
445.50%27.86M
-2.67%-7.88M
Income tax
Net income
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
128.21%8.03M
25.99%-4.64M
-9.25%-7.64M
453.13%28.01M
-6.08%-7.7M
Net income continuous Operations
-365.90%-18.65M
-20.01%-6.2M
18.89%-6.33M
-128.53%-7.95M
123.20%1.83M
123.85%7.01M
21.74%-5.16M
-10.34%-7.81M
445.50%27.86M
-2.67%-7.88M
Net income discontinuous operations
22.31%1.24M
-43.76%293K
--0
--0
431.46%946K
6.52%1.01M
60.31%521K
106.25%165K
12.88%149K
-57.00%178K
Minority interest income
Net income attributable to the parent company
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
128.21%8.03M
25.99%-4.64M
-9.25%-7.64M
453.13%28.01M
-6.08%-7.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
128.21%8.03M
25.99%-4.64M
-9.25%-7.64M
453.13%28.01M
-6.08%-7.7M
Basic earnings per share
-190.45%-62.48
68.08%-13.3414
66.67%-22
-122.04%-54.12
125.16%17.16
125.86%69.08
25.20%-41.8
-4.90%-66
418.86%245.52
5.49%-68.2
Diluted earnings per share
-190.45%-62.48
68.08%-13.3414
66.67%-22
-122.04%-54.12
125.16%17.16
125.86%69.08
25.20%-41.8
-4.90%-66
418.86%245.52
5.49%-68.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 00000-74.67%3.11M00028.62%3.11M
Operating revenue --0--0--0--0--0-74.67%3.11M--0--0--028.62%3.11M
Cost of revenue
Gross profit
Operating expense -9.06%28.88M-16.92%6.38M-15.71%6.56M8.15%8.18M-11.11%7.76M-5.75%31.76M-0.27%7.68M-0.79%7.78M-14.38%7.56M-6.27%8.73M
Selling and administrative expenses -15.15%11.77M-7.21%2.79M-19.14%2.67M-26.54%2.72M-7.02%3.59M-5.61%13.87M-4.81%3.01M-4.94%3.31M-10.05%3.7M-2.23%3.86M
-General and administrative expense -15.15%11.77M-7.21%2.79M-19.14%2.67M-26.54%2.72M-7.02%3.59M-5.61%13.87M-4.81%3.01M-4.94%3.31M-10.05%3.7M-2.23%3.86M
Research and development costs -4.33%17.11M-23.17%3.59M-13.18%3.89M41.32%5.46M-14.34%4.17M-5.85%17.88M2.88%4.67M2.52%4.48M-18.15%3.87M-9.25%4.87M
Operating profit -0.83%-28.88M16.92%-6.38M15.71%-6.56M-8.15%-8.18M-38.23%-7.76M-33.84%-28.64M-90.20%-7.68M-63.87%-7.78M-32.16%-7.56M18.54%-5.61M
Net non-operating interest income expense
Other net income (expense) -71.31%10.23M-92.54%188K1,008.00%227K-99.35%230K523.28%9.58M545.24%35.66M198.59%2.52M98.93%-25K1,612.51%35.42M-189.51%-2.26M
Special income (charges) --9.65M--0--0--0--9.65M--0--0--0--0--0
-Gain on sale of property,plant,equipment --9.65M--0--0--0--9.65M--0--0--0--0--0
Other non- operating income (expenses) -98.38%578K-92.54%188K1,008.00%227K-99.35%230K97.04%-67K545.24%35.66M198.59%2.52M98.93%-25K1,612.51%35.42M-189.51%-2.26M
Income before tax -365.90%-18.65M-20.01%-6.2M18.89%-6.33M-128.53%-7.95M123.20%1.83M123.85%7.01M21.74%-5.16M-10.34%-7.81M445.50%27.86M-2.67%-7.88M
Income tax
Net income -316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M128.21%8.03M25.99%-4.64M-9.25%-7.64M453.13%28.01M-6.08%-7.7M
Net income continuous Operations -365.90%-18.65M-20.01%-6.2M18.89%-6.33M-128.53%-7.95M123.20%1.83M123.85%7.01M21.74%-5.16M-10.34%-7.81M445.50%27.86M-2.67%-7.88M
Net income discontinuous operations 22.31%1.24M-43.76%293K--0--0431.46%946K6.52%1.01M60.31%521K106.25%165K12.88%149K-57.00%178K
Minority interest income
Net income attributable to the parent company -316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M128.21%8.03M25.99%-4.64M-9.25%-7.64M453.13%28.01M-6.08%-7.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M128.21%8.03M25.99%-4.64M-9.25%-7.64M453.13%28.01M-6.08%-7.7M
Basic earnings per share -190.45%-62.4868.08%-13.341466.67%-22-122.04%-54.12125.16%17.16125.86%69.0825.20%-41.8-4.90%-66418.86%245.525.49%-68.2
Diluted earnings per share -190.45%-62.4868.08%-13.341466.67%-22-122.04%-54.12125.16%17.16125.86%69.0825.20%-41.8-4.90%-66418.86%245.525.49%-68.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg